424 filings
Page 11 of 22
F-3/A
tkm 1v611
12 Feb 20
Shelf registration (foreign) (amended)
5:31pm
6-K
c4gr y5j4
12 Feb 20
Current report (foreign)
4:46pm
6-K
uwpvwqv
3 Feb 20
Current report (foreign)
2:59pm
6-K
texi excg67qdxk
3 Feb 20
European Medicines Agency recommends indication expansion of AmeluzĀ® for treatment of actinic keratoses on the extremities and trunk/neck
6:41am
6-K
uqecy4
31 Jan 20
Current report (foreign)
1:18pm
UPLOAD
nhb0x jrhg
28 Jan 20
Letter from SEC
12:00am
F-3
qauwl3
22 Jan 20
Shelf registration (foreign)
5:28pm
6-K
xaoa0kf5ht5l
22 Jan 20
Current report (foreign)
5:20pm
6-K
lkyx j3ezdezgk
14 Jan 20
Current report (foreign)
10:34am
6-K
ckcpgva10mye0opdyr
10 Jan 20
Biofrontera announces preliminary sales figures for the full year 2019, record sales in the 4th quarter
6:04am
6-K
tb4s8h1shhv3 xe815u
6 Jan 20
Biofrontera strengthens commercial focus with reorganization of its US business
9:52am
6-K
rbrjn9t91yl iyug7
20 Dec 19
Current report (foreign)
12:23pm
6-K
7gt 27etf8zqc8yu8z
13 Dec 19
Current report (foreign)
8:41am
6-K
5jh36te1 c3i14k8m
12 Dec 19
1. Details of the person discharging managerial responsibilities / person closely associated
9:30am
6-K
7th4fku7g8o5hfaoyd
12 Dec 19
1. Details of the person discharging managerial responsibilities / person closely associated
9:29am
6-K
i802061vy 09jzlh8
12 Dec 19
1. Details of the person discharging managerial responsibilities / person closely associated
9:29am
6-K
vhza4y4ic9fdjicx3d
2 Dec 19
1. Details of the person discharging managerial responsibilities / person closely associated
7:56am
6-K
turgke0 mqkebvg
2 Dec 19
1. Details of the person discharging managerial responsibilities / person closely associated
7:55am
6-K
gyhq wer6iiw7
2 Dec 19
1. Details of the person discharging managerial responsibilities / person closely associated
7:53am
6-K
xk1e04u3w v3u1oksyvu
2 Dec 19
1. Details of the person discharging managerial responsibilities / person closely associated
7:52am